NMC Health Plc (LSE:NMC) commences share repurchases on December 18, 2019, under the program mandated by the shareholders in the General Meeting held on December 5, 2019. As per the mandate, the company is authorized to repurchase up to 20,890,386 shares, representing 10% of the issued share capital. The maximum price which may be paid for an ordinary share is an amount equal to the higher of 105% of the average of the middle market quotations for the ordinary shares taken from the London Stock Exchange Daily Official List for five business days immediately preceding the day on which that share is contracted to be purchased and an amount equal to the higher of the price of the last independent trade and the highest current independent bid on the trading venues where the purchase is carried out at the relevant time. The minimum price which may be paid for an ordinary share is 10 pence. The repurchased shares will be cancelled. The program will be valid till the next Annual General Meeting in 2020, or June 30, 2020, whichever is earlier. As at November 19, 2019, the company had 208,903,861 shares in issue.